Celosia Therapeutics
PrivateLast Round
Series A
Nov 28, 2024
Total Funding Raised
$12.92M
Company Overview
Celosia Therapeutics is a biotechnology company that develops precision gene therapies for neurodegenerative diseases, including ALS, FTD, and Alzheimer's disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Celosia Therapeutics Comparables
Compare Celosia Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Avrion Therapeutics AG | 85% | |
| QurAlis | 79% | |
| VectorY Therapeutics | 78% | |
Celosia Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 28, 2024 | ||||
| Seed | Oct 31, 2022 |
Key People
Founding team and executive leadership
Celosia Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UniSuper Management | Series A |
| Uniseed | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 28, 2024
$11M round led by Uniseed.
- Oct 31, 2022
Raised $2M in seed funding.
Celosia Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Celosia Therapeutics's valuation, stock price, and market status.